Rabies Vaccine Market is estimated to reach $970 million by 2029, and is observed to grow at a CAGR of 6.9% during forecast period of 2023-2029.
Rabies vaccine is an adsorbed virus vaccine which acts by inducing an active immune response to promote immunity. Rabies without actually causing the disease works by provoking the bodies immune response to this virus. When the body is exposed to foreign organisms such as bacteria and viruses, the immune system produces antibodies against them. These antibodies help the body to recognize and kill the foreign organisms. Thus these antibodies remain in the body to help protect the body against future infections with the same organism, which is known as active immunity
The Global “Rabies Vaccine Market” research report give detailed information with reference to market size, share, trends, growth, cost revenue, capacity, and forecast till 2029. This report also contains the general and in-depth study of the Rabies Vaccine market with all its aspects influencing the growth of the market. The purpose of the Market survey report is to thoroughly evaluate the current market scenario and gain a review about the Rabies Vaccine Market and its commercial possibilities. As a consequence of the Russia-Ukraine War and COVID-19, the world economy will recover, and generate a lot of revenue till 2029.
Click Here To Get a Free Sample Copy with Detailed Analysis, Tables and Figures.
Key Players Mentioned in the Rabies Vaccine Market Research Report:
GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Industry News and Updates:
In April 2022, Cadila Pharmaceuticals launched a three-dose recombinant nanoparticle-based G protein rabies vaccine in Ahmedabad. This is a three-dose regimen to be given over a period of one week (on day 0, day three, and day seven) after exposure to the virus. It is the first in a long list of existing rabies vaccines that require five doses.
In August 2020, Bavarian Nordic A/S announced that it was starting commercial operations in the United States for Rabipur/RabAvert (Rabies Vaccine) and Encepur (Tick-Borne Encephalitis Vaccine) after acquiring them from GlaxoSmithKline plc (GSK).
On The Basis of Types: -
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
On The Basis of Application: -
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
The post-exposure prophylaxis segment is estimated to witness maximum growth through 2029. Over 20 million people receive post-exposure prophylaxis treatment per year, and the vaccine has been proven as an effective control measure to rabies for more than 100 years. The safety and efficacy related to the product, along with lower awareness regarding pre-exposure prophylaxis across under-developed regions, will boost segmental revenue share over the analysis period.
The regions are further sub-divided into:
- North America (US, Mexico, Canada)
- Europe (Russia, Ukraine, France, Spain, Sweden, Norway, Germany, Finland, Poland, Italy, United Kingdom, Greece, Austria, Denmark, Switzerland, Netherlands, Belgium, Turkey, Luxembourg)
- Asia-Pacific (China, Japan, India, Australia, South Korea, Taiwan, Malaysia, Philippines, Thailand, Singapore)
- South America (Brazil, Argentina, Peru, Chile)
- Middle East and Africa (Bahrain, Egypt, Israel, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, South Africa)
Russia-Ukraine War Impact 2023: Economic Sanctions Imposed by the United States & its Allies on the Russian Federation Negatively Affected the Market.
“The economic sanctions imposed by the U.S. and its allies on the Russian Federation are expected to affect this Market’s growth. Furthermore, the war negatively affected the global industries leading to import and export flow disruptions. The dominance of Russia and roscosmos, a quasi-civilian space agency in the commercial space, affected alternative launch service providers in India, Japan, Europe, and the U.S. These factors negatively affected the Market during the war."
The impact of the Rabies Vaccine Market report:
- Comprehensive assessment of all opportunities and risk in the Rabies Vaccine Market.
- Rabies Vaccine Market recent innovations and major events.
- Detailed study of business strategies for growth of the Rabies Vaccine Market-leading players.
- Conclusive study about the growth plot of Rabies Vaccine Market for forthcoming years.
- In-depth understanding of Rabies Vaccine Market-particular drivers, constraints and major micro industries.
- Favourable impression inside vital technological and Market latest trends striking the Rabies Vaccine Market.
Browse Full Report at:
Key Takeaways from Rabies Vaccine Report
─Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different market verticals
─Understand the different dynamics influencing the Rabies Vaccine market – key driving factors, challenges and hidden opportunities.
─Get in-depth insights on your competitor performance – Rabies Vaccine market shares, strategies, financial benchmarking, product benchmarking, SWOT and more
─Analyze the sales and distribution channels across key geographies to improve top-line revenues.
─Understand the market supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
─Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
─Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the Rabies Vaccine.
The survey covers historical data from 2018 to 2023 and predictions through 2029, making it a priceless tool for business leaders, marketing, sales, and product managers, consultants, analysts, and stakeholders searching for essential Market data in easily accessible documents with logically laid out tables and graphs.
We Offer Customization on Report Based on Specific Client Requirement:
- Free Country Level analysis for any 5 countries of your choice.
- Free Competitive analysis of any 5 key Market players.
- Free 40 analyst hours to cover any other data point.
- Free 15% customization equal to 60 analyst hours.
About Us:
MarketInsightsReports provides syndicated Market survey on market verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Market, etc. MarketInsightsReports provides global and regional Market intelligence coverage, a 360-degree Market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com